Prognostic significance of CD163 expression in colorectal cancer stroma: a retrospective cohort study
- Nauryzbay Imanbayev
(West Kazakhstan Marat Ospanov State Medical University, Aktobe, Department of oncology, Kazakhstan)
- Yerbolat Iztleuov
(West Kazakhstan Marat Ospanov State Medical University, Aktobe, Department of Radiology, Kazakhstan)
- Arip Koyshybaev
(West Kazakhstan Marat Ospanov State Medical University, Aktobe, Department of Oncology, Kazakhstan)
- Aigul Zhumasheva
(West Kazakhstan Marat Ospanov State Medical University, Aktobe, Medical Centre, 4. Department of Pathomorphology, Kazakhstan)
- Beibit Baizakov
(West Kazakhstan Marat Ospanov State Medical University, Aktobe, Department of Radiology, Kazakhstan)
- Nurgul Kereyeva
(West Kazakhstan Marat Ospanov State Medical University, Aktobe, Department of Oncology, Kazakhstan)
- Zhanna Satenova
(West Kazakhstan Marat Ospanov State Medical University, Aktobe, Department of Oncology, Kazakhstan)
- Aigerim Imanbayeva
(West Kazakhstan Marat Ospanov State Medical University, Aktobe, Medical Centre, 8. Department of Pathomorphology, Kazakhstan)
- Anara Tulyayeva
(West Kazakhstan Marat Ospanov State Medical University, Aktobe, Department of Oncology, Kazakhstan)
- Dinara Zholmukhamedova
(West Kazakhstan Marat Ospanov State Medical University, Aktobe, Department of Oncology, Kazakhstan)
- Marzhan Aitmagambetova
(West Kazakhstan Marat Ospanov State Medical University, Aktobe, Department of Oncology, Kazakhstan)
- Azamat Zharylgapov
(West Kazakhstan Marat Ospanov State Medical University, Aktobe, Department of Oncology, Kazakhstan)
Abstract
Aim: Colorectal cancer (CRC) ranks among the leading causes of cancer-related mortality worldwide, with significant incidence and mortality rates recorded in Kazakhstan. CRC poses a substantial healthcare burden, prompting investigations into novel prognostic markers.
Aim: This study investigates the prognostic significance of CD163 expression in patients with colorectal cancer.
Methods: This retrospective cohort study was conducted in Aktobe, Kazakhstan, utilizing tissue microarrays from 175 patients diagnosed with Tumor, Node, Metastasis (TNM) stage I-IV colon adenocarcinoma. CD163 expression was assessed through immunohistochemistry. Kaplan-Meier survival analysis was employed to estimate 5-year overall survival, defined as the interval from diagnosis to death or last follow-up. Cox proportional hazards models were used to evaluate the relationship between CD163 expression levels and survival outcomes.
Results: High CD163 expression was linked to advanced disease stage of colorectal cancer (p < 0.001), lymphovascular invasion (p < 0.001), perineural invasion (p < 0.001), and Collagen I>30%, A type (p<0.001). CD163 infiltration was a negative prognostic factor for colorectal cancer patients, with higher risks of death in the high CD163 expression group compared to the low CD163 group (HR=5.769, 95% CI 3.194 - 10.42, p<0.001).
Conclusion: The findings highlight CD163 as a potential prognostic biomarker in CRC, warranting further investigation into its mechanistic role and therapeutic implications.
Keywords: adenocarcinoma, biomarkers tumor, immunohistochemistry, survival analysis, tumor microenvironment
How to Cite:
Imanbayev, N., Iztleuov, Y., Koyshybaev, A., Zhumasheva, A., Baizakov, B., Kereyeva, N., Satenova, Z., Imanbayeva, A., Tulyayeva, A., Zholmukhamedova, D., Aitmagambetova, M. & Zharylgapov, A., (2025) “Prognostic significance of CD163 expression in colorectal cancer stroma: a retrospective cohort study”, Medicinski glasnik 22(2), 253-257. doi: https://doi.org/10.17392/1848-22-02
Downloads:
Download PDF
View PDF
0 Views
0 Downloads